[ { "@id": "http://purl.org/np/RAySK-31NxhJAtKuFF_ytCHfpLYrFRXPWh6IRW_TwfwBY#Head", "@graph": [ { "@id": "http://purl.org/np/RAySK-31NxhJAtKuFF_ytCHfpLYrFRXPWh6IRW_TwfwBY", "http://www.nanopub.org/nschema#hasAssertion": [ { "@id": "http://purl.org/np/RAySK-31NxhJAtKuFF_ytCHfpLYrFRXPWh6IRW_TwfwBY#assertion" } ], "http://www.nanopub.org/nschema#hasProvenance": [ { "@id": "http://purl.org/np/RAySK-31NxhJAtKuFF_ytCHfpLYrFRXPWh6IRW_TwfwBY#provenance" } ], "http://www.nanopub.org/nschema#hasPublicationInfo": [ { "@id": "http://purl.org/np/RAySK-31NxhJAtKuFF_ytCHfpLYrFRXPWh6IRW_TwfwBY#pubinfo" } ], "@type": [ "http://www.nanopub.org/nschema#Nanopublication" ] } ] }, { "@id": "http://purl.org/np/RAySK-31NxhJAtKuFF_ytCHfpLYrFRXPWh6IRW_TwfwBY#pubinfo", "@graph": [ { "@id": "http://purl.org/np/RAySK-31NxhJAtKuFF_ytCHfpLYrFRXPWh6IRW_TwfwBY#sig", "http://purl.org/nanopub/x/hasAlgorithm": [ { "@value": "RSA" } ], "http://purl.org/nanopub/x/hasPublicKey": [ { "@value": "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCC0CnI6yMUipkXh7RB8b/9rRnO8+qDR+pJVf//jGV0r2nd7JcvWFkhPN/eLja/pUw/+nvTE24rhKqK/jWxppJLoka+bk57wrYw43DrSbzQWoJc3ImWe3d08jSYt3mh3uOLWKciogBaonJUBohJsqhTmOULevIPONTZOMzeOJTWwQIDAQAB" } ], "http://purl.org/nanopub/x/hasSignature": [ { "@value": "Faw6TOn8LOES/hlXXOPeRS7wPrrQjJf8wI2fOqyMon3C0KZai6JugAqvKyMBfgsaIgZ2BkQ+MJfNDqssJIDy+5EOMyGdasPBCP9Mp2Kwdnq3O2Nt0NfDvPv5GUiwJyw5/IDNrcqefpYD1JzgmRLxmc8GaW4s74r55J82tqXcMgw=" } ], "http://purl.org/nanopub/x/hasSignatureTarget": [ { "@id": "http://purl.org/np/RAySK-31NxhJAtKuFF_ytCHfpLYrFRXPWh6IRW_TwfwBY" } ] }, { "@id": "http://purl.org/np/RAySK-31NxhJAtKuFF_ytCHfpLYrFRXPWh6IRW_TwfwBY", "http://purl.org/dc/terms/created": [ { "@value": "2021-04-04T21:34:28.183+02:00", "@type": "http://www.w3.org/2001/XMLSchema#dateTime" } ], "http://purl.org/dc/terms/creator": [ { "@id": "https://orcid.org/0000-0003-4665-7473" } ], "https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate": [ { "@id": "http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM" } ], "https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate": [ { "@id": "http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM" } ], "https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate": [ { "@id": "http://purl.org/np/RA64ptuigOfVGfIhpdwWeJnssaHV9jTQCnAm6Pvgrvmos" } ] } ] }, { "@id": "http://purl.org/np/RAySK-31NxhJAtKuFF_ytCHfpLYrFRXPWh6IRW_TwfwBY#provenance", "@graph": [ { "@id": "http://purl.org/np/RAySK-31NxhJAtKuFF_ytCHfpLYrFRXPWh6IRW_TwfwBY#assertion", "http://www.w3.org/ns/prov#wasAttributedTo": [ { "@id": "https://orcid.org/0000-0003-4665-7473" } ] } ] }, { "@id": "http://purl.org/np/RAySK-31NxhJAtKuFF_ytCHfpLYrFRXPWh6IRW_TwfwBY#assertion", "@graph": [ { "@id": "http://purl.obolibrary.org/obo/DOID_1826", "https://schema.org/possibleTreatment": [ { "@id": "http://purl.org/np/RAySK-31NxhJAtKuFF_ytCHfpLYrFRXPWh6IRW_TwfwBY#medtherapy" } ] }, { "@id": "http://purl.org/np/RAySK-31NxhJAtKuFF_ytCHfpLYrFRXPWh6IRW_TwfwBY#medtherapy", "http://www.w3.org/ns/prov#wasDerivedFrom": [ { "@id": "http://purl.org/np/RAySK-31NxhJAtKuFF_ytCHfpLYrFRXPWh6IRW_TwfwBY#quote" } ], "https://schema.org/drug": [ { "@id": "http://identifiers.org/drugbank/DB00949" } ], "https://schema.org/targetPopulation": [ { "@id": "http://purl.org/np/RAySK-31NxhJAtKuFF_ytCHfpLYrFRXPWh6IRW_TwfwBY#targetpop" } ], "https://w3id.org/neurodkg/indicationType": [ { "@id": "https://w3id.org/neurodkg/SymptomaticReliefIndication" } ] }, { "@id": "http://purl.org/np/RAySK-31NxhJAtKuFF_ytCHfpLYrFRXPWh6IRW_TwfwBY#quote", "http://www.w3.org/ns/prov#value": [ { "@value": "Felbamate oral suspension is recommended for use only in those patients who respond inadequately to alternative treatments and whose epilepsy is so severe that a substantial risk of aplastic anemia and/or liver failure is deemed acceptable in light of the benefits conferred by its use" } ], "http://www.w3.org/ns/prov#wasQuotedFrom": [ { "@id": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2e325d79-d0a4-4af7-b09b-96ee5a5b2a37" } ] } ] } ]